Sam Conaway is a strategic senior leader in the medical device industry known for his compassion and entrepreneurial spirit. His experience in healthcare spans over 40 years, and he is driven to improve access to care for women and people of color.
As President, U.S. Cardiology Sales, Sam provides strategic direction for U.S. commercial cardiology sales which includes Atrial Fibrillation Solutions (LAAC & Electrophysiology Therapies), Cardiac Rhythm Management & Diagnostics and Interventional Cardiology & Structural Heart Therapies. As a member of the Cardiology Group executive team and Chair of Close the Gap, a Boston Scientific health equity initiative, Sam influences commercial strategy and engagement across the entire Cardiology portfolio and leads cross-functional teams focused on strategic alliances that enable Boston Scientific’s compelling value proposition. The convergence of Sam’s leadership roles within Boston Scientific positions him to wrap meaning around innovation.
Sam was recognized by SAVOY Magazine (2022) as one of the Most Influential Black Executives in Corporate America, was recipient of Cardiovascular Research Foundation’s Inaugural Pulse-Setter Leader Award (2022) and honored by BlackDoctor.org in 2022 as one of fourteen Top Blacks in Healthcare.
Sam holds an MBA from the University of Maryland Global Campus, and a BS Degree from the University of Phoenix. Sam sits on the boards of JDP and the International Andreas Gruentzig Society.